The mission of every team member at Carmat is to contribute to the development of innovative artificial organs – the artificial heart today, tomorrow other vital organs – to treat millions of patients affected by advanced disease of these organs and to restore their normal life.

By sharing our expertise and through our daily actions, we seek to achieve results that will benefit first and foremost patients and physicians, but also healthcare systems, subcontractors, employees and shareholders.

Type
Public
HQ
Vélizy-Villacoublay, FR
Founded
2008
Employees
48 (est)
Carmat was founded in 2008 and is headquartered in Vélizy-Villacoublay, FR

Carmat Locations

Vélizy-Villacoublay, FR

Carmat Metrics

Carmat Summary

Market capitalization

€136 M

Closing share price

€29.2
Carmat's current market capitalization is €136 M.

Carmat Market Value History

Carmat Online Presence

Carmat Company Life